ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984

Data On CT Screening For Lung Cancer Raises Questions About DOD Program

April 23, 2010

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

Mark Israel To Direct Norris Cotton Center

October 19, 2001

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977